Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hazlehurst JM, and Tomlinson JW (2013)Non-alcoholic fatty liver disease in common endocrine disorders 169:R27-37. doi: https://doi.org/10.1530/EJE-13-0296
Nascimbeni F, Pais R, Bellentani S et al (2013) From NAFLD in clinical practice to answers from guidelines. J Hepatol 59:859–871
Zhu JZ, Dai YN, Wang YM et al (2015) Prevalence of nonalcoholic fatty liver disease and economy. Dig Dis Sci 60:3194–3202
Bell LN, Theodorakis JL, Vuppalanchi R et al (2010) Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology 51:111–120
Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the Amer-ican Gastroenterological Association. Hepatology 55:2005–2023
Ratziu V, Giral P, Charlotte F et al (2000) Liver fibrosis in overweight patients. Gastroenterology 118:1117–1123
Angulo P, Hui JM, Marchesini G et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45:846–854
Machado MV, Cortex-Pinto H (2013) Noninvasive diagnosis of non-alcoholic fatty liver disease: A critical appraisal. J Hepatol 58:1007–1019
Kam RK, Deng Y, Chen Y. et al. (2012) Retinoic acid synthesis and functions in early embyronic developement Cell Biosci 2: 11.
Mondul A, Mancina RM, Merlo A et al (2015) PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity. J Nutr 145:1687–1691
Senoo H, Yoshikawa K, Morii M et al (2010) Hepatic stellate cell (vitamin A-stor-ing cell) and it’s relative – past, present and future. Cell Biol Int 34:1247–1272
Rinella M.(2015)Non-alcoholic fatty liver disease: a systematic review313:2263-73. doi: https://doi.org/10.1001/jama.2015.5370.
Bonet ML, Ribot J, Palou A (2012) Lipid metabolism in mammalian tissues and its control by retinoic acid. Biochim Biophys Acta 1821:177–189
Liu Y, Chen H, Wang J et al (2015) Association of serum retinoic acid with hepatic steatosis and liver injury in non-alcoholic fatty liver disease. Am J Clin Nutr 102:130–137
Chaves G, Pereira SE, Saboya CJ et al (2008) Non-alcoholic Fatty Liver Disease and Its Relationship with the Nutritional Status of Vitamin A in Individuals with Class III Obesity. Obes Surg 18:378. https://doi.org/10.1007/s11695-007-9361-2
Botella-Carretero JI, Balsa JA, Vázquez C et al (2010) Retinol and alpha-tocopherol in morbid obesity and nonalcoholic fatty liver disease. Obes Surg 20:69–76
Miyazaki M, Kato M, Tanaka K et al (2012) Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep 5:729–733
Mourad F, El Sayeda Z, Showmana H, Abo RM, Mohamed N (2018) The role of serum retinol in nonalcoholic fatty liver disease. Sci J Al-Azhar Med Fac Girls 2:115–122
Pettinelli P, Arendt BM, Teterina A, McGilvray I, Comelli EM, Fung SK, Fischer SE, Allard JP (2018) Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease. PLoS One. 13:e0205747
Cengiz C, Ardicoglu Y, Bulut S, Boyacioglu S (2010) Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis? Eur J Gastroenterol Hepatol 22:813–819